TP53 and metastatic malignant neoplasm in the lymph nodes: In contrast, Trovik et al. reported an abnormal pathologic TP53 expression in 24% of EC samples, which was associated with an older age at diagnosis, advanced stage, lymph node metastasis, non-endometrioid subtype, and advanced histologic grade.